Definition, prognostic assessment, and advances in the diagnosis and treatment of acute-on-chronic liver failure

Zhanhu BI; Linxu WANG; Jianqi LIAN

doi:10.3969/j.issn.1001-5256.2022.07.041

Volume 38 Issue 7

Jul. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(7): 1671-1676

PDF( 1880 KB)

Definition, prognostic assessment, and advances in the diagnosis and treatment of acute-on-chronic liver failure

DOI: 10.3969/j.issn.1001-5256.2022.07.041

Department of Infectious Diseases, The Second Affiliated Hospital of Air Force Medical University, Xi'an 710038, China

More Information

Corresponding author: LIAN Jianqi, lianjq@fmmu.edu.cn
Received Date: 2022-01-04
Published Date: 2022-07-20

Abstract

Abstract

Acute-on-chronic liver failure (ACLF) is a clinical syndrome with acute decompensation of liver function on the basis of chronic liver diseases, and at present, there is still no unified definition standard for this disease in the world. ACLF is characterized by rapid progression of liver disease, multiple organ failure, and high short-term mortality. Chronic viral hepatitis and alcoholic liver disease are the most common chronic liver diseases, and infection, alcohol, and hepatotoxic drugs are the main predisposing factors for this disease, but up to 40%-50% of ACLF cases have no identifiable predisposing factors. Early identification and accurate assessment of disease conditions are crucial to ACLF patients, but there is still a lack of ideal assessment methods for early warning and accurate assessment. Currently, the main treatment methods are organ support and treatment of complications, and liver transplantation is the only treatment method that can improve prognosis; however, there are still controversies over the selection of appropriate patients and the timing of liver transplantation.
- Acute-on-Chronic Liver Failure,
- Prognosis,
- Diagnosis,
- Therapeutics

FullText(HTML)

References(51)

References

[1]	WU T, LI J, SHAO L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. Gut, 2018, 67(12): 2181-2191. DOI: 10.1136/gutjnl-2017-314641.
[2]	SARIN SK, KEDARISETTY CK, ABBAS Z, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J]. Hepatol Int, 2014, 8(4): 453-471. DOI: 10.1007/s12072-014-9580-2.
[3]	SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update[J]. Hepatol Int, 2019, 13(4): 353-390. DOI: 10.1007/s12072-019-09946-3.
[4]	MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144(7): 1426-1437, 1437. e1-9. DOI: 10.1053/j.gastro.2013.02.042.
[5]	BAJAJ JS, O'LEARY JG, REDDY KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures[J]. Hepatology, 2014, 60(1): 250-256. DOI: 10.1002/hep.27077.
[6]	O'LEARY JG, REDDY KR, GARCIA-TSAO G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis[J]. Hepatology, 2018, 67(6): 2367-2374. DOI: 10.1002/hep.29773.
[7]	HERNAEZ R, KRAMER JR, LIU Y, et al. Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA[J]. J Hepatol, 2019, 70(4): 639-647. DOI: 10.1016/j.jhep.2018.12.018.
[8]	BAJAJ JS, O'LEARY JG, LAI JC, et al. Acute-on-chronic liver failure clinical guidelines[J]. Am J Gastroenterol, 2022, 117(2): 225-252. DOI: 10.14309/ajg.0000000000001595.
[9]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Arificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[10]	FERNÁNDEZ J, ACEVEDO J, WIEST R, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis[J]. Gut, 2018, 67(10): 1870-1880. DOI: 10.1136/gutjnl-2017-314240.
[11]	MVCKE MM, RUMYANTSEVA T, MVCKE VT, et al. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality[J]. Liver Int, 2018, 38(4): 645-653. DOI: 10.1111/liv.13568.
[12]	LIU XQ, ZHANG XY, YING Y, et al. The role of prophylactic antibiotics in hepatitis B virus-related acute-on-chronic liver failure patients at risk of bacterial infection: a retrospective study[J]. Infect Dis Poverty, 2021, 10(1): 44. DOI: 10.1186/s40249-021-00830-7.
[13]	ZACCHERINI G, WEISS E, MOREAU R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2021, 3(1): 100176. DOI: 10.1016/j.jhepr.2020.100176.
[14]	LIU XY, HU JH, LI C, et al. Clinical features of patients with acute-on-chronic liver failure and bacterial infection and influencing factors for prognosis[J]. J Clin Hepatol, 2021, 37(9): 2148-2152. DOI: 10.3969/j.issn.1001-5256.2021.09.028. 刘晓燕, 胡瑾华, 李晨, 等. 慢加急性肝衰竭合并细菌感染患者的临床特征及预后影响因素分析[J]. 临床肝胆病杂志, 2021, 37(9): 2148-2152. DOI: 10.3969/j.issn.1001-5256.2021.09.028.
[15]	TREBICKA J, BORK P, KRAG A, et al. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 167-180. DOI: 10.1038/s41575-020-00376-3.
[16]	BERNAL W, JALAN R, QUAGLIA A, et al. Acute-on-chronic liver failure [J]. The Lancet, 2015, 386(10003): 1576-1587. DOI: 10.1016/s0140-6736(15)00309-8.
[17]	LO RE V 3rd, CARBONARI DM, LEWIS JD, et al. Oral azole antifungal medications and risk of acute liver injury, overall and by chronic liver disease status[J]. Am J Med, 2016, 129(3): 283-291. e5. DOI: 10.1016/j.amjmed.2015.10.029.
[18]	CHALASANI N, BONKOVSKY HL, FONTANA R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study[J]. Gastroenterology, 2015, 148(7): 1340-1352. e7. DOI: 10.1053/j.gastro.2015.03.006.
[19]	DEVARBHAVI H, CHOUDHURY AK, SHARMA MK, et al. Drug-induced acute-on-chronic liver failure in asian patients[J]. Am J Gastroenterol, 2019, 114(6): 929-937. DOI: 10.14309/ajg.0000000000000201.
[20]	SUNDARAM V, JALAN R, AHN JC, et al. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(3): 617-625. DOI: 10.1016/j.jhep.2018.04.016.
[21]	DUSEJA A, DE A, TANEJA S, et al. Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure[J]. Liver Int, 2021, 41(1): 150-157. DOI: 10.1111/liv.14671.
[22]	LIU CR, LI YP, LUO S, et al. Influencing factors for the short-term prognosis of patients with HBV-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(1): 56-62. DOI: 10.3969/j.issn.1001-5256.2021.01.012. 刘晨瑞, 李亚萍, 罗森, 等. HBV相关慢加急性肝衰竭患者短期预后的影响因素分析[J]. 临床肝胆病杂志, 2021, 37(1): 56-62. DOI: 10.3969/j.issn.1001-5256.2021.01.012.
[23]	PUGH RNH, MURRAY-LYON IM, DAWSON JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60: 646-649.
[24]	MALINCHOC M, KAMATH PS, GORDON FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4): 864-871. DOI: 10.1053/he.2000.5852.
[25]	BIGGINS SW, KIM WR, TERRAULT NA, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660. DOI: 10.1053/j.gastro.2006.02.010.
[26]	LUCA A, ANGERMAYR B, BERTOLINI G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis[J]. Liver Transpl, 2007, 13(8): 1174-1180. DOI: 10.1002/lt.21197.
[27]	Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006. 中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
[28]	KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470. DOI: 10.1053/jhep.2001.22172.
[29]	HERNAEZ R, LIU Y, KRAMER JR, et al. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure[J]. J Hepatol, 2020, 73(6): 1425-1433. DOI: 10.1016/j.jhep.2020.06.005.
[30]	ABDALLAH MA, KUO YF, ASRANI S, et al. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality[J]. J Hepatol, 2021, 74(6): 1355-1361. DOI: 10.1016/j.jhep.2020.12.003.
[31]	VINCENT JL, MORENO R, TAKALA J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine[J]. Intensive Care Med, 1996, 22(7): 707-710. DOI: 10.1007/BF01709751.
[32]	ZHENG YX, ZHONG X, LI YJ, et al. Performance of scoring systems to predict mortality of patients with acute-on-chronic liver failure: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2017, 32(10): 1668-1678. DOI: 10.1111/jgh.13786.
[33]	ZHANG Y, NIE Y, LIU L, et al. Assessing the prognostic scores for the prediction of the mortality of patients with acute-on-chronic liver failure: a retrospective study[J]. Peer J, 2020, 8: e9857. DOI: 10.7717/peerj.9857.
[34]	JALAN R, SALIBA F, PAVESI M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure[J]. J Hepatol, 2014, 61(5): 1038-1047. DOI: 10.1016/j.jhep.2014.06.012.
[35]	LI N, HUANG C, YU KK, et al. Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF[J]. Medicine (Baltimore), 2017, 96(17): e6802. DOI: 10.1097/MD.0000000000006802.
[36]	BAROSA R, ROQUE RAMOS L, PATITA M, et al. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward[J]. Rev Esp Enferm Dig, 2017, 109(6): 399-405. DOI: 10.17235/reed.2017.4701/2016.
[37]	TONG JJ, ZHAO W, MU XY, et al. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin Med J (Engl), 2019, 132(13): 1541-1549. DOI: 10.1097/CM9.0000000000000298.
[38]	HERNAEZ R, SOLÀ E, MOREAU R, et al. Acute-on-chronic liver failure: an update[J]. Gut, 2017, 66(3): 541-553. DOI: 10.1136/gutjnl-2016-312670.
[39]	SOLÉ C, GUILLY S, DA SILVA K, et al. Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics: relationship with acute-on-chronic liver failure and prognosis[J]. Gastroenterology, 2021, 160(1): 206-218. e13. DOI: 10.1053/j.gastro.2020.08.054.
[40]	ARROYO V, MOREAU R, JALAN R, et al. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis[J]. J Hepatol, 2015, 62(1 Suppl): S131-S143. DOI: 10.1016/j.jhep.2014.11.045.
[41]	LIU H, ZHANG Q, LIU L, et al. Effect of artificial liver support system on short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Artif Organs, 2020, 44(10): E434-E447. DOI: 10.1111/aor.13710.
[42]	HUANG K, JI F, XIE Z, et al. Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis[J]. Sci Rep, 2019, 9(1): 16462. DOI: 10.1038/s41598-019-53029-0.
[43]	Transplantation Immunology Committee of Branch of Organ Transplantation Physician of Chinese Medical Doctor Association, Enhanced Recovery of Liver Transplantation Group of Enhanced Recovery after Surgery Committee of Chinese Research Hospital Society. Expert consensus on perioperative management of liver transplantation in adults with acute-on-chronic liver failure[J]. Ogran Transplant, 2020, 11(5): 533-542. DOI: 10.3969/j.issn.1674-7445.2020.05.001. 中国医师协会器官移植医师分会移植免疫学专业委员会, 中国研究型医院学会加速康复外科委员会肝移植加速康复学组. 成人慢加急性肝衰竭肝移植围手术期管理专家共识[J]. 器官移植, 2020, 11(5): 533-542. DOI: 10.3969/j.issn.1674-7445.2020.05.001.
[44]	SUNDARAM V, MAHMUD N, PERRICONE G, et al. Longterm outcomes of patients undergoing liver transplantation for acute-on-chronic liver failure[J]. Liver Transpl, 2020, 26(12): 1594-1602. DOI: 10.1002/lt.25831.
[45]	SUNDARAM V, JALAN R, WU T, et al. Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation[J]. Gastroenterology, 2019, 156(5): 1381-1391. e3. DOI: 10.1053/j.gastro.2018.12.007.
[46]	TOMESCU D, POPESCU M, BIANCOFIORE G. Liver transplantation for acute-on-chronic liver failure[J]. Best Pract Res Clin Anaesthesiol, 2020, 34(1): 25-33. DOI: 10.1016/j.bpa.2019.12.001.
[47]	HUEBENER P, STERNECK MR, BANGERT K, et al. Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival[J]. Aliment Pharmacol Ther, 2018, 47(11): 1502-1510. DOI: 10.1111/apt.14627.
[48]	FAN Q, LI Z. Liver transplantation for acute-on-chronic liver failure[J]. Organ Transplantat, 2022, 13(3): 333-337. DOI: 10.3969/j.issn.1674-7445.2022.03.008. 范祺, 李照. 慢加急性肝衰竭的肝移植治疗[J]. 器官移植, 2022, 13(3): 333-337. DOI: 10.3969/j.issn.1674-7445.2022.03.008.
[49]	SHI M, ZHANG Z, XU R, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients[J]. Stem Cells Transl Med, 2012, 1(10): 725-731. DOI: 10.5966/sctm.2012-0034.
[50]	GARG V, GARG H, KHAN A, et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure[J]. Gastroenterology, 2012, 142(3): 505-512. e1. DOI: 10.1053/j.gastro.2011.11.027.
[51]	ENGELMANN C, HERBER A, FRANKE A, et al. Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study)[J]. J Hepatol, 2021, 75(6): 1346-1354. DOI: 10.1016/j.jhep.2021.07.033.

Relative Articles

[1]	Zhiying LIU, Zhihang ZHOU, Song HE. Research advances in the role of blood metabolic markers in the treatment response and prognosis prediction of primary liver cancer[J]. Journal of Clinical Hepatology, 2023, 39(10): 2470-2475. doi: 10.3969/j.issn.1001-5256.2023.10.028
[2]	Yuhang CHEN, Zimeng JIANG, Zhijiao ZHANG, Mengyao ZHENG, Meilian WANG, Hua HUANG, Gongfang ZHAO. The influence of diagnostic criteria of different guidelines on short-term prognosis of artificial liver therapy for acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(11): 2629-2634. doi: 10.3969/j.issn.1001-5256.2023.11.017
[3]	Ying TU, Xue LI, Meijuan CHEN, Huaqian XU, Shanhong TANG. Value of platelet count and related scoring models in predicting the prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(6): 1308-1312. doi: 10.3969/j.issn.1001-5256.2023.06.009
[4]	Lin LIU, Ling WANG, Shanhong TANG. Value of monocyte to high-density lipoprotein cholesterol ratio in predicting the short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(8): 1841-1847. doi: 10.3969/j.issn.1001-5256.2023.08.012
[5]	Huaqian XU, Xue LI, Shanhong TANG. Research advances in the role of inflammatory response and related treatment strategies in acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2022, 38(8): 1927-1930. doi: 10.3969/j.issn.1001-5256.2022.08.041
[6]	Xiaomei QIN, Shuangjie LI. Etiology, diagnosis, and treatment of acute liver failure in neonates[J]. Journal of Clinical Hepatology, 2022, 38(2): 260-263. doi: 10.3969/j.issn.1001-5256.2022.02.002
[7]	Shuo YANG, Kun LIU, Lan YANG, Ling XU, Xiaobo LU, Xiaofeng SUN, MALIPATI Elkenjiang. Value of lactate level in predicting the short-term prognosis of patients with acute-on-chronic hepatitis B liver failure[J]. Journal of Clinical Hepatology, 2022, 38(7): 1482-1488. doi: 10.3969/j.issn.1001-5256.2022.07.007
[8]	Chinese Society for Emergency Medicine, Beijing-Tianjin-Hebei Alliance of Emergency Treatment and First Aid, Emergency Medicine Branch, Beijing Medical Association, Emergency Physicians Branch, Beijing Medical Doctor Association, Emergency Treatment and First Aid Branch, China Health Culture Association. Expert consensus on emergency diagnosis and treatment of acute pancreatitis[J]. Journal of Clinical Hepatology, 2021, 37(5): 1034-1041. doi: 10.3969/j.issn.1001-5256.2021.05.012
[9]	Yu WANG, Min WANG, Guanhua ZHANG, Fuliang HE, Xiaojuan OU, Jidong JIA. Clinical diagnosis, staging, and therapeutic principles of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 17-21. doi: 10.3969/j.issn.1001-5256.2021.01.004
[10]	Ying XU, Xiaoping HUANG, Li CHEN, Wei SUN, Wenting LI, Yan WANG, Jianhe GAN. Value of high-density lipoprotein cholesterol in evaluating the severity and prognosis of hepatitis B virus-associated acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2021, 37(7): 1632-1635. doi: 10.3969/j.issn.1001-5256.2021.07.030
[11]	Jinling DONG, Yu CHEN. Prognostic grade of acute-on-chronic liver failure: Different outcomes of the same disease[J]. Journal of Clinical Hepatology, 2021, 37(9): 2030-2032. doi: 10.3969/j.issn.1001-5256.2021.09.006
[12]	YANG Xu, SUN WenBing, GAO Jun. Diagnosis and treatment of hepatic vascular tumors[J]. Journal of Clinical Hepatology, 2020, 36(11): 2569-2573. doi: 10.3969/j.issn.1001-5256.2020.11.039
[13]	Luo Qiong, Wang ChunMing, Liao HangYu, Chen KunLing, Pan MingXin. Value of the NDRG family in the diagnosis and prognostic evaluation of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(6): 1284-1288. doi: 10.3969/j.issn.1001-5256.2020.06.019
[14]	Xu Ying, Huang XiaoPing, Chen Li, Gu Jing, Wang Yan, Gan JianHe. Value of mean platelet volume in evaluating the prognosis of hepatitis B virus-associated acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2020, 36(10): 2199-2202. doi: 10.3969/j.issn.1001-5256.2020.10.008
[15]	Xu XiaoLei, Gao CanCan, Wang ZhiXin, Wang Zhan, ZHOU Ying, Wang HaiJiu, Ye HaiWen, Pang MingQuan, Zhou Hu, Hou YaJun, Guo Bing, Fan HaiNing. Advances in the diagnosis and treatment of cystic space-occupying lesions in the liver[J]. Journal of Clinical Hepatology, 2019, 35(5): 1118-1122. doi: 10.3969/j.issn.1001-5256.2019.05.043
[16]	Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and therapy of hepatic fibrosis(2019)[J]. Journal of Clinical Hepatology, 2019, 35(10): 2163-2172. doi: 10.3969/j.issn.1001-5256.2019.10.007
[17]	Sun FuRong, Wang BingYuan. Severe alcoholic hepatitis and acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(3): 489-493. doi: 10.3969/j.issn.1001-5256.2019.03.008
[18]	Zhang Jing, Zhou XinMin. Value of five scoring systems in predicting short-term mortality of patients with acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(9): 1990-1994. doi: 10.3969/j.issn.1001-5256.2019.09.021
[19]	Liu Juan, Bai FeiYun, Zhang Jing. Research advances in diagnostic criteria for acute-on-chronic liver failure and models for prognostic evaluation[J]. Journal of Clinical Hepatology, 2019, 35(6): 1384-1387. doi: 10.3969/j.issn.1001-5256.2019.06.046
[20]	Lin Feng. Research advances in clinical diagnosis,prognostic evaluation,and treatment of liver failure[J]. Journal of Clinical Hepatology, 2016, 32(9): 1678-1683. doi: 10.3969/j.issn.1001-5256.2016.09.009

Supplements(0)

Cited By

Cited by

Periodical cited type(16)

1.	刘韦，白浪. 慢加急性肝衰竭动物模型研究现状. 临床肝胆病杂志. 2024(01): 187-192 . 本站查看
2.	鞠宇豪，李文，王雨，肖玲燕，郑以山，韩国荣. 41例慢性HBV感染危重孕产妇的临床特征分析. 临床肝胆病杂志. 2024(02): 258-263 . 本站查看
3.	叶丽丽，肖畅，张应泉，冯笑玲. 某传染病三甲医院肝病科近10年出院患者疾病谱分析. 中国病案. 2024(02): 55-57 .
4.	窦侠玲，庄玉，周秋. 慢加急性肝衰竭患者短期预后预测模型的构建与验证. 当代护士(中旬刊). 2024(02): 138-142 .
5.	唐露露，陈怀珍，张静，董婷，李俊，江海林，杨文明. Wilson病相关慢加急性肝衰竭患者预后影响因素及其预测价值. 解放军医学杂志. 2024(02): 131-136 .
6.	毕占虎，王临旭，胡海峰，杜虹，丁一迪，杨晓飞，詹家燚，胡飞，余登辉，徐洪凯，连建奇. 慢加急性肝衰竭合并细菌感染患者的临床特征及早期预警指标筛选. 临床肝胆病杂志. 2024(04): 760-766 . 本站查看
7.	郑云杰，张涛，孙克伟. 孙克伟教授运用温法治疗慢加急性肝衰竭的经验. 湖南中医药大学学报. 2024(04): 650-654 .
8.	龚红梅，毛青，蒋黎. 人工智能在慢加急性肝衰竭预后评估中的应用研究进展. 医学新知. 2024(04): 473-480 .
9.	万康，叶艳清. 慢加急性肝衰竭预后评分系统最新研究进展. 黑龙江医学. 2024(11): 1404-1406+1409 .
10.	易小玲，顾杨，李莉，余涛. 基于GEO数据库的脓毒症诱发慢加急性肝衰竭关键基因的生物信息学探究. 岭南现代临床外科. 2024(03): 157-161 .
11.	安逸远，刘俊平，康谊，陈宁，魏迅. 总胆汁酸与乙型肝炎相关慢加急性肝衰竭患者继发感染的关系. 中华实用诊断与治疗杂志. 2024(11): 1111-1116 .
12.	刘思晨，胡敬宝，叶火成，柴俊杰，倪琳雅，黄晓敏，鲁艳平. 牛角地黄解毒汤对慢加急性肝衰竭患者肝脏功能及凝血功能的影响研究. 广州中医药大学学报. 2024(12): 3161-3166 .
13.	张斌，迪丽胡玛尔·扎依尔，张诗雨，朱彬，黄红明，田进，王宝菊. 乙型肝炎相关慢加急性肝衰竭发病机制及治疗进展. 中国肝脏病杂志(电子版). 2023(01): 28-33 .
14.	黄玉梅，宋佳音，李荣唐. 预后营养指数对老年慢加急性肝衰竭患者预后的评估价值. 中国老年学杂志. 2023(10): 2398-2401 .
15.	武羽，董金玲，徐曼曼，陈慧娜，邹怀宾，白丽，陈煜. 慢加急性肝衰竭：基于起病表现的新型临床分型特征及预后分析. 临床肝胆病杂志. 2023(10): 2375-2382 . 本站查看
16.	郭北辰，李雨韩，陈蕊，王乐微，李莹，刘芳，徐曼曼，陈煜，段钟平，辛绍杰，韩涛. MELD 3.0、MELD和MELD-Na评分对慢加急性肝衰竭患者短期预后的评估价值. 临床肝胆病杂志. 2023(11): 2635-2642 . 本站查看

Other cited types(7)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (1612) PDF downloads(319)

Definition, prognostic assessment, and advances in the diagnosis and treatment of acute-on-chronic liver failure

DOI: 10.3969/j.issn.1001-5256.2022.07.041

Abstract

References

Relative Articles

Cited by

Periodical cited type(16)

Other cited types(7)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content